Cargando…
Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
Prostate cancer (PC) can be kept in check by androgen deprivation therapy (ADT, usually with the androgen synthesis inhibitor abiraterone acetate or the androgen receptor antagonist such as enzalutamide) until the tumor evolves to castration-resistant prostate cancer (CRPC). The transition of hormon...
Autores principales: | Terrisse, Safae, Zitvogel, Laurence, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714294/ https://www.ncbi.nlm.nih.gov/pubmed/36483309 http://dx.doi.org/10.15698/mic2022.12.787 |
Ejemplares similares
-
Impact of microbiota on breast cancer hormone therapy
por: Terrisse, Safae, et al.
Publicado: (2023) -
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
por: Terrisse, Safae, et al.
Publicado: (2022) -
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?
por: Patrikidou, Anna, et al.
Publicado: (2021) -
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
por: Terrisse, Safae, et al.
Publicado: (2021) -
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)